Fitton Isabelle, Charpentier Etienne, Arsovic Emina, Isaia Jennifer, Guillou Manon, Saltel-Fulero Aurélien, Fournier Laure, Van Ngoc Ty Claire
Department of Radiology, Georges Pompidou European Hospital, Paris Cité University, APHP, 75015 Paris, France.
PARCC UMRS 970, INSERM, 75015 Paris, France.
J Clin Med. 2024 Aug 6;13(16):4597. doi: 10.3390/jcm13164597.
To define and evaluate a radiation dose optimization process for chest computed tomography (CT) imaging. Data from unenhanced and enhanced chest CT acquisitions performed between June 2018 and January 2020 in adult patients were included in the study. Images were acquired on a Siemens SOMATOM Definition Edge CT. Dose values, including Dose.Length Product (DLP) and Volume CT Dose Index (CTDI), were collected. Low doses (LDs, 25th percentiles), achievable doses (ADs, 50th percentiles), and diagnostic reference levels (DRLs, 75th percentiles) were calculated before and after parameter modifications. A process was defined and applied to patient data. For unenhanced chest CT, data were differentiated according to three groups: high dose (HD), optimized dose (OD), and ultra-low dose (ULD). Dosimetric changes between protocols were expressed as mean CTDI % (CI95%). A Mann and Whitney statistical test was used. The diagnostic quality score (DQS) of a subset of 70 randomly selected CT examinations was evaluated by one radiologist. The DQS was scored according to a three-point Likert scale: (1) poor (definite diagnosis impossible), (2) fair (evaluation of major findings possible), and (3) excellent (exact diagnosis possible). : Data were collected from 1929 patients. For unenhanced chest CT protocols, only one process loop was run. A dose comparison between the chest CT protocol before the use of the process and the three groups showed a decrease of -38.3% (9.7%) and -93.4% (24.2%) for OD and ULD, respectively, and an increase of +29.4% (4.7%) for HD. For the enhanced chest CT protocol, two optimization loops were performed, and they resulted in a mean dose reduction of -50.0% (2.6%) compared to the pre-optimization protocol. For all protocols, the DQS was greater than or equal to 2. : We proposed a radiation dose optimization process for chest CT that could significantly reduce the dose without compromising diagnosis.
定义并评估胸部计算机断层扫描(CT)成像的辐射剂量优化流程。本研究纳入了2018年6月至2020年1月期间对成年患者进行的非增强和增强胸部CT扫描数据。图像通过西门子SOMATOM Definition Edge CT获取。收集了包括剂量长度乘积(DLP)和容积CT剂量指数(CTDI)在内的剂量值。在参数修改前后计算低剂量(LD,第25百分位数)、可实现剂量(AD,第50百分位数)和诊断参考水平(DRL,第75百分位数)。定义了一个流程并应用于患者数据。对于非增强胸部CT,数据根据三组进行区分:高剂量(HD)、优化剂量(OD)和超低剂量(ULD)。不同方案之间的剂量学变化以平均CTDI%(CI95%)表示。采用曼恩-惠特尼统计检验。由一名放射科医生对70例随机选择的CT检查子集的诊断质量评分(DQS)进行评估。DQS根据三点李克特量表评分:(1)差(无法明确诊断),(2)一般(可评估主要发现),(3)优(可准确诊断)。:从1929例患者收集数据。对于非增强胸部CT方案,仅运行一个流程循环。使用该流程前的胸部CT方案与三组之间的剂量比较显示,OD组和ULD组分别降低了-38.3%(9.7%)和-93.4%(24.2%),HD组增加了+29.4%(4.7%)。对于增强胸部CT方案,进行了两个优化循环,与优化前方案相比,平均剂量降低了-50.0%(2.6%)。对于所有方案,DQS均大于或等于2。:我们提出了一种胸部CT辐射剂量优化流程,该流程可在不影响诊断的情况下显著降低剂量。